GPT and metabolic dysfunction-associated steatotic liver disease: Animals treated in groups D and E showed significantly reduced ALT levels (p < 0.05) in comparison to those of group B, indicating that animals of these groups recovered from NAFLD in a better way as compared to the other groups.